Cleared Traditional

K100135 - GDS-DC12

K100135 is an FDA 510(k) clearance for GDS-DC12, manufactured by Guided Delivery Systems. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 87-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2010
Decision
87d
Days
Class 2
Risk

K100135 is an FDA 510(k) clearance for the GDS-DC12. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Guided Delivery Systems (Santa Clara, US). The FDA issued a Cleared decision on April 16, 2010 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Guided Delivery Systems devices

FDA 510(k) Submission Details - K100135

510(k) Number K100135 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 19, 2010
Decision Date April 16, 2010
Days to Decision 87 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 125d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 669
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K100135.
LEV-OR DILATION CATHETER OTW
K101117 · Baylis Medical Co., Inc. · Jul 2010
PENUMBRA CATHERER 025
K100826 · Penumbra, Inc. · Jul 2010
CLEARWAY OTW MODEL 85912
K093431 · Atrium Medical Corp. · Apr 2010
ACUITY BREAK-AWAY GUIDE CATHETER
K093969 · Cardiac Pacemakers, Inc. · Mar 2010
ASAHI ZENYTEEX GUIDING CATHETER
K091188 · Asahi Intecc Co., Ltd. · Feb 2010
ARROW SELDINGER ARTERIAL CATHERIZATION DEVICES, MODELS EX SAC 00520
K093050 · Arrow Intl., Inc. · Dec 2009